FDA Brief

Company record

Champaklal Maganlal Homeo Pharmacy Private Limited

2 FDA warning letters since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Champaklal Maganlal Homeo Pharmacy Private Limited.

Warning letters

  1. Champaklal Maganlal Homeo Pharmacy Private Limited

    FDA says Champaklal Maganlal Homeo Pharmacy's Bebelyn diarrhea and colic products are unapproved new drugs for infants.

    High risk
  2. Champaklal Maganlal Homeo Pharmacy Private Limited

    Champaklal Maganlal Homeo Pharmacy failed to test each glycerin lot for identity, including DEG/EG, in OTC and homeopathic drugs.

    High risk